K. Imaki

Gas chromatographic — Mass spectrometric quantitation of 16,16-dimethyl-trans-Δ2-PGE1

M. Bygdeman, Y. Konishi, K. Gréen, 1983 .

ONO-5046, a novel inhibitor of human neutrophil elastase.

M. Suzuki, M. Toda, M. Sugitani, 1991, Biochemical and biophysical research communications.

Inhibitory effects of ONO-3307 on various proteases and tissue thromboplastin in vitro and on experimental thrombosis in vivo.

H. Ohno, T. Okegawa, A. Kawasaki, 1989, Japanese journal of pharmacology.

The levels of main urinary metabolite of prostaglandin F1α and F2α in human subjects measured by radioimmunoassay

N. Nakazawa, M. Kurono, S. Ohki, 1976 .

Non-peptidic inhibitors of human neutrophil elastase: the design and synthesis of sulfonanilide-containing inhibitors.

Y. Nakayama, H. Nakai, M. Kawamura, 1996, Bioorganic & medicinal chemistry.

Radioimmunoassays of prostaglandin F2α and prostaglandin F2α-main urinary metabolite with prostaglandin-125I-tyrosine methylester amide

N. Nakazawa, S. Ohki, F. Hirata, 1974 .

Radioimmunoassay of main urinary metabolite of prostaglandin F2alpha.

N. Nakazawa, F. Hirata, K. Imaki, 1975, Prostaglandins.

Potent orally active inhibitors of angiotensin-converting enzyme (ACE).

M. Toda, T. Okegawa, A. Kawasaki, 1981, Chemical & pharmaceutical bulletin.

Simplified immunoassays of prostaglandin E main metabolite in human urine.

H. Masuda, F. Hirata, K. Imaki, 1983, Advances in prostaglandin, thromboxane, and leukotriene research.